Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Which Future Health Risk Should Cancer Treatment Survivors Watch Most Closely?

Which Future Health Risk Should Cancer Treatment Survivors Watch Most Closely?

Breast cancer mortality has declined substantially over 40 years. However, on 16 December 2019, Cancer published a study reporting survivors' most common cause of death as cardiovascular disease . Today, completed-treatment survivors are estimated at 46 million people are estimated to be living today. As survivor numbers rise, the proportions and causes of noncancer deaths require evaluation in this population. A large, long-term study revealed suspected causes. Between 2000 – 2015, over 750.000 American women were assessed, and heart disease emerged as the leading cause of death among breast cancer survivors. Within 1 year after diagnosis, noncancer deaths accounted for % 28; among women surviving more than 10 years, this proportion was slightly above % 60. Long-term survivors had significantly increased risk of both heart disease and Alzheimer disease versus the general population. Previously suspected causes can now be assessed objectively and may relate to chemotherapy and radiotherapy adverse effects are suspected contributors, and these associations have now become clearer. For example, women treated with radiotherapy to the left breast as part of breast cancer treatment may later experience long-term heart problems and coronary artery disease.

Study Features and Results:

• The study included 754.270 women. Most common was % 61.2 stage-1 breast cancer. During follow-up, % 24.3 died at average age 72.6.

• Most deaths (% 46.2) occurred 1 to 5 years after diagnosis (all death proportions: first 1 year % 16.3; 5 to 10 years % 27.6; after 10 years % 10.3).

• Within the first year, % 65.4 died of breast cancer, % 6.7 other cancers, and % 27.9 noncancer causes. In that first 1 year, leading noncancer causes were heart disease (% 10), cerebrovascular disease (% 2.4), and chronic obstructive pulmonary disease (COPD).

• At 1 to 5 years, % 58,6 died of breast cancer, % 8,9 other cancers, and % 32,4 noncancer causes. Heart disease led at % 11.2, followed by cerebrovascular deaths at % 2.7, COPD at % 3, and Alzheimer at % 1.6.

• At 5 to 10 years, causes were breast cancer % 38,2, other cancers % 13,4, and noncancer % 48,4. Heart disease led noncancer deaths (% 15.7), followed by cerebrovascular disease (% 3.9), COPD (% 3.9), and Alzheimer (% 3.4).

• After 10 years, breast cancer caused % 23,6 of deaths, other cancers % 15,5, and noncancer causes % 60,9. Leading noncancer causes were heart disease (% 19,3), Alzheimer (% 5,3), cerebrovascular disease (% 5,2), and COPD (% 4,9).

In conclusion, improved treatments and early diagnosis allow more patients normal lives, but noncancer illnesses increasingly affect survivors. Patients and oncology professionals must not overlook this; postcancer life must be part of health care.

Sources

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Which Future Health Risk Should Cancer Treatment Survivors Watch Most Closely?

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy